Drug Trial Radar · NCT07369154
52-week Open Label Safety-Tolerability Study
Last checked: Nov 19, 2026Latest source record: Sep 9, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
900
Planned (sponsor's estimate)
Start
Apr 23, 2026
Primary completion
Dec 2028
Study completion Apr 2029
Sponsor
- Lead sponsor
- LB Pharmaceuticals Inc.Industry
- Sponsor type
- Industry
- First posted
- Jan 27, 2026
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 65 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Phase 3, open label, multicenter study designed to assess the long term safety and tolerability of LB-102 for the treatment of adult patients with stable schizophrenia
Conditions
- Schizophrenia
Interventions
LB-102Drug
LB-102 flexible dosing 50 mg - 100 mg
Primary outcomes
What the sponsor says the trial is designed to measure.
- Evaluate long term safety and tolerability of LB-102 by evaluating the number of adverse event, incidence of treatment emergent events.Time frame: 52 weeks
Locations
23 sites in 1 country. Site status is shown where the registry gives one.
Chandler Clinical Trials
Chandler, Arizona · Recruiting
Pillar Clinical Research
Bentonville, Arkansas · Recruiting
Pillar Clinical Research
Little Rock, Arkansas · Recruiting
Woodland International Research Group
Little Rock, Arkansas · Recruiting
Advanced Research Center
Anaheim, California · Recruiting
Synapse Clinical Trials
Cerritos, California · Recruiting
ProScience Research Group
Culver City, California · Recruiting
CenExel
Culver City, California · Recruiting
Synergy San Diego
San Diego, California · Recruiting
CenExel
Hollywood, Florida · Recruiting
Segal Trials
Miami Lakes, Florida · Recruiting
Health Synergy Clinical Research
West Palm Beach, Florida · Recruiting
CenExel
Atlanta, Georgia · Recruiting
Accelerated Clinical Trial
Snellville, Georgia · Recruiting
Pillar Clinical Research
Chicago, Illinois · Recruiting
CenExel Gaithersburg
Gaithersburg, Maryland · Recruiting
Arch Clinical Trials
St Louis, Missouri · Recruiting
Redbird Research
Las Vegas, Nevada · Recruiting
Neuro-Behavioral Clinical Research
New York, New York · Recruiting
Neuro-Behavioral Clinical Research
Canton, Ohio · Recruiting
Adams Clinical
Philadelphia, Pennsylvania · Recruiting
Adams Clinical
DeSoto, Texas · Recruiting
Pillar Clinical Research
Richardson, Texas · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.